NCPA submitted comments to the Senate Finance Committee’s minority leadership on its request for information on lowering drug prices.
We argued that pharmacies must be reimbursed for both ingredient costs and dispensing fees for pharmacies to be economically viable. Similarly, we argued that for contracts to be reasonable and relevant, pharmacies must be compensated based on acquisition cost and a commensurate professional dispensing fee, in line with Medicaid fee-for-service.
We also asked Congress to ensure that LTC pharmacy reimbursement applies regardless of care setting and to prohibit PBMs from limiting LTC reimbursement to skilled nursing or intermediate care facilities, consistent with CMS recognition that LTC pharmacy services are furnished across a broader continuum of care that includes assisted living communities and beneficiaries’ homes.
Read the comments here.
